Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocean Biomedical

0.0415
-0.0017-3.94%
Post-market: 0.0402-0.0014-3.25%19:59 EDT
Volume:8.48M
Turnover:340.20K
Market Cap:6.89M
PE:-0.12
High:0.0420
Open:0.0418
Low:0.0370
Close:0.0432
Loading ...

Why this drone maker is braving turbulent markets for an IPO

Dow Jones
·
11 Apr

Ocean Biomedical Delays Yearly Report Filing

TIPRANKS
·
02 Apr

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting Chi3l1 and Pd1 for Enhanced Tumor Cell Cytotoxicity in China

THOMSON REUTERS
·
28 Mar

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

GlobeNewswire
·
28 Mar

Trump's shipbuilding plan could upend ocean cargo industry, companies warn

Reuters
·
08 Mar

Dow Falls 100 Points; Coca-Cola Posts Upbeat Earnings

Benzinga
·
11 Feb

Ocean Biomedical announces findings in EGFR-mutant lung cancer

TIPRANKS
·
10 Feb

BRIEF-Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer

Reuters
·
10 Feb

Ocean Biomedical- to Initiate Preclinical Studies to Advance Immunotherapy Program & to Engage With FDA for First-in-Human Trials

THOMSON REUTERS
·
10 Feb

Ocean Biomedical Announces Breakthrough Findings in Egfr-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

THOMSON REUTERS
·
10 Feb

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

GlobeNewswire
·
10 Feb

Ocean Biomedical Receives Additional NIH Funding for Malaria Vaccine Research; Shares Up Pre-Bell

MT Newswires Live
·
29 Jan

Ocean Biomedical advances malaria vaccine research with new funding, pathway

TIPRANKS
·
29 Jan

Ocean Biomedical Advances Malaria Vaccine Research With New Nih Funding and Expedited Development Pathway

THOMSON REUTERS
·
29 Jan

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

GlobeNewswire
·
29 Jan

Ocean Biomedical Inc - Receives Nasdaq Non-Compliance Notice for Minimum Bid Price

THOMSON REUTERS
·
10 Dec 2024

Ocean Biomedical Faces Nasdaq Delisting Threat

TIPRANKS
·
23 Nov 2024

BRIEF-Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q

Reuters
·
23 Nov 2024

Ocean Biomedical, Inc. Announces Receipt of Notice From Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

THOMSON REUTERS
·
23 Nov 2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

GlobeNewswire
·
23 Nov 2024